NCT03994978 is a clinical trial of elective sigmoidectomy in Diverticulitis of Sigmoid, sponsored by University Hospital, Basel, Switzerland.

Who is sponsoring NCT03994978?

NCT03994978 is sponsored by University Hospital, Basel, Switzerland.

What drugs are being tested in NCT03994978?

Interventions in NCT03994978: elective sigmoidectomy.

What condition does NCT03994978 study?

NCT03994978 studies Diverticulitis of Sigmoid.

Is NCT03994978 still recruiting?

NCT03994978 is currently completed. Last updated 4 January 2023.

Last reviewed 2023-01-04 · How we verify

NCT03994978

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bowel Function/QoL After Elective Sigmoidectomy vs. Conservative Management for Recurrent Uncomplicated Diverticulitis

Completed Last updated 4 January 2023

What this trial tests

trial testing elective sigmoidectomy in Diverticulitis of Sigmoid in 252 participants. Completed in 27 December 2022.

Timeline

8 July 2019

Primary endpoint
1 December 2022

27 December 2022

Quick facts

Lead sponsor	University Hospital, Basel, Switzerland
Status	Completed
Study type	OBSERVATIONAL
Enrollment	252
Start date	8 July 2019
Primary completion	1 December 2022
Estimated completion	27 December 2022
Sites	1 location across Switzerland

Drugs / interventions tested

elective sigmoidectomy

Conditions studied

Diverticulitis of Sigmoid — all drugs for Diverticulitis of Sigmoid →

Sponsor

University Hospital, Basel, Switzerland

Who can join

18 and older, any sex, with Diverticulitis of Sigmoid. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The decision to perform a surgical intervention or not after recovery from repeated uncomplicated episodes of acute diverticulitis remains controversial and the literature shows different conflicting approaches based on low-quality evidence.The goal of this trial is to achieve a better understanding of the impact of surgery on bowel function and QoL in patients with recurrent uncomplicated sigmoid diverticulitis in order to develop treatment guidelines.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Basel, Switzerland trials

Trials by the same sponsor.

NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03994978 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
Last refreshed: 4 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03994978.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing